NCT06169033 Radiomics of Intra-abdominal and Subcutaneous Adipose Tissue Predict the Efficacy of Bariatric Surgery (RISABS)
| NCT ID | NCT06169033 |
| Status | Recruiting |
| Phase | — |
| Sponsor | China-Japan Friendship Hospital |
| Condition | Obesity |
| Study Type | OBSERVATIONAL |
| Enrollment | 800 participants |
| Start Date | 2024-01-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 800 participants in total. It began in 2024-01-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Using radiomics of intra-abdominal and subcutaneous adipose tissue and clinical features to predict the weight loss efficacy and remission of type 2 diabetes mellitus after bariatric surgery.
Eligibility Criteria
Inclusion Criteria: * BMI\>27.5kg/m2; Type 2 diabetes mellitus; Patients who will undergo bariatric surgery Exclusion Criteria: * Patients without abdominal CT scan; Patients did not undergo sleeve gastrectomy or Roux-en-Y gastric bypass.
Contact & Investigator
Yuntao Nie, M.D.
PRINCIPAL INVESTIGATOR
China-Japan Friendship Hospital
Frequently Asked Questions
Who can join the NCT06169033 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 70 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06169033 currently recruiting?
Yes, NCT06169033 is actively recruiting participants. Contact the research team at nytnyt1231@163.com for enrollment information.
Where is the NCT06169033 trial being conducted?
This trial is being conducted at Beijing, China.
Who is sponsoring the NCT06169033 clinical trial?
NCT06169033 is sponsored by China-Japan Friendship Hospital. The principal investigator is Yuntao Nie, M.D. at China-Japan Friendship Hospital. The trial plans to enroll 800 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.